The medical imaging technology developer raised cash in a series B round backed by GE, Varian, Fosun, Northwell Health and NewYork-Presbyterian.
Month: November 2017
Philo files away $25m
A+E, AMC, Discovery, Scripps and Viacom supplied the funding as part of a commercial partnership that will involve their channels being available on Philo’s streaming service.
Element AI accesses Korea for $45m fund
The artificial intelligence startup has combined with Korea-based corporates SK Telecom, Hyundai Motor and Hanwha for the strategic fund.
MitrAssist gets $30m funding implant
Fosun Pharma and Ping An were among the investors that are providing $30m for MitrAssist in a two-tranche round.
9f Group accounts for nine-figure series C
The SIG-backed peer-to-peer lending marketplace has announced it has raised hundreds of millions of dollars in its latest round.
Ziff Davis pays $50m for Mashable acquisition
Media groups Time Warner and Tribune Media have exited Mashable, the digital media brand valued at $250m just 18 months ago.
Maoyan validates $150m investment ticket
Tencent has invested in Maoyan at a $3bn valuation, two months after the ticketing platform agreed to merge with its peer Weiying Technology.
Flipkart to deliver $50m to Swiggy
Flipkart is reportedly about to provide $50m for Naspers-backed food delivery platform Swiggy, while Tencent could make a similar investment.
Assemble Systems constructs $12m series A
Autodesk’s Forge Fund led the round as part of a strategic partnership with construction software provider Assemble Systems.
News round up 20 November 2017
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Inozyme signs up for $49m series A
Novo and Sanofi have backed a series A round for Inozyme Pharma, which is developing treatments for rare diseases affecting infants.
Intel moves to Bossa Nova in series B
Autonomous robot developer Bossa Nova Robotics has secured $17.5m in an Intel-backed round that will support company growth.
Locus closes $19m series A
Tencent has backed antimicrobial therapy developer Locus Biosciences in a $19m round that will fund the company’s first in-human clinical trial.
Behavox forms Citigroup relationship to raise $20m
Citigroup has led a $20m series A1 round for Behavox, a developer of people analytics software for the financial services industry.